References
- Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082–2090. doi:10.1056/NEJMoa04411315901861
- Shea K, Edelsberg J, Weycker D, Farkouh R, Strutton D, Pelton S. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014. doi:10.1093/ofid/ofu024
- Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. Clin Infect Dis. 2014;59(5):615–623. doi:10.1093/cid/ciu34824825867
- Peyrani P, Ramirez JA. One-year mortality in patients with community-acquired pneumonia. Univ Louisville J Respir Infect. 2017;1:44–49.
- Bornheimer R, Shea KM, Sato R, Weycker D, Pelton SI. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017;12(10):e0184877. doi:10.1371/journal.pone.018487729028810
- Bordon J, Aliberti S, Fernandez-Botran R, et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. J Infect Dis. 2013;17(2):e76–e83.
- Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118(11):3546–3556. doi:10.1172/JCI3613018982161
- Kang HR, Choi GS, Park SJ, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis. 2014;77:209–214. doi:10.4046/trd.2014.77.5.209
- Gibson PG, Yan IA, Upham JW, Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo–controlled trial. Lancet. 2017;390:659–668. doi:10.1016/S0140-6736(17)31281-3
- Centers for Disease Control and Prevention. Immunization Schedules. Available from: https://www.cdc.gov/vaccines/schedules/easy-to-read/adult-conditions-easyread.html. Accessed 130, 2019.